HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Clinical trial NCT04995003 · RECRUITING

Trial details

NCT number: NCT04995003
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Sarcoma HER-2 Protein Overexpression Osteosarcoma Rhabdomyosarcoma Ewing Sarcoma Synovial Sarcoma Soft Tissue Sarcoma Undifferentiated Sarcoma

Start date: 2021-12-07
Primary completion: 2028-06-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.